From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.60
First Reported 2003
Last Reported 2005
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.15
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (TDGF1) extracellular space (TDGF1) Golgi apparatus (TDGF1)
plasma membrane (TDGF1) nucleus (TDGF1) embryo development (TDGF1)
Anatomy Link Frequency
bowel 1
TDGF1 (Homo sapiens)
Pain Link Frequency Relevance Heat
cINOD 5 50.00 Quite Low
Crohn's disease 4 50.00 Quite Low
Nicotine 2 50.00 Quite Low
Inflammation 4 10.00 Low Low
Disease Link Frequency Relevance Heat
Disease 4 77.80 Quite High
INFLAMMATION 4 76.52 Quite High
Cancer 2 50.00 Quite Low
Necrosis 2 50.00 Quite Low
Nicotine Addiction 1 5.00 Very Low Very Low Very Low
Inflammatory Bowel Disease 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
RESULTS: Nicotine did not affect barrier function in vivo, nor gastric emptying, small-bowel transit time or orocaecal transit. 51Cr-EDTA and lactulose correlated in basal 0-6 h permeability testing (r = 0.529, P < 0.0001), as did 6-24 h excretion of 51Cr-EDTA and sucralose (r = 0.474, P < 0.001); 97% and 90% of the subjects had a permeability increase after indomethacin intake for 0-6 h and 6-24 h excretion of Cr-EDTA, respectively.
Localization (excretion) of Cr-EDTA in bowel
1) Confidence 0.60 Published 2003 Journal Scand. J. Gastroenterol. Section Body Doc Link 12739712 Disease Relevance 0 Pain Relevance 0
Intestinal permeability was studied by measurement of urinary excretion of Cr-EDTA after oral intake.
Localization (excretion) of Cr-EDTA
2) Confidence 0.00 Published 2005 Journal Inflamm. Bowel Dis. Section Body Doc Link 15973122 Disease Relevance 0.15 Pain Relevance 0

General Comments

This test has worked.

Personal tools